GlaxoSmithKline Sales Growth, Dividend

July 26 (Bloomberg) -- Andrew Witty, chief executive officer at GlaxoSmithKline Plc, discusses the outlook for the company. Glaxo today reported second-quarter earnings per share excluding some items of 25 pence, meeting the average estimate of analysts surveyed by Bloomberg. Witty speaks with Shannon Pettypiece on Bloomberg Television's "InBusiness With Margaret Brennan." (Source: Bloomberg)